Ojos De Hojalata/Getty Images
Blood type is essential for safe transfusions, but emerging research suggests it may also signal susceptibility to certain health conditions. Recent studies indicate that individuals with AB blood type could face a higher risk of cognitive decline as they age. While findings are not yet definitive, the possibility warrants attention.
Bymuratdeniz/Getty Images
Human blood is categorized into four primary types—A, B, AB, and O—each with positive and negative variants. AB negative is the rarest, present in only 0.6% of the U.S. population, followed by AB positive at 3.4%. A 2014 Neurology study following 30,239 adults aged 45 and older found that those with AB blood were 82% more likely to develop cognitive or memory problems that could precede dementia compared to other types.
The study tracked participants for an average of 3.4 years, identifying 495 individuals who developed new cognitive issues and 587 who remained unimpaired. Among those with emerging problems, 6% carried AB blood, versus 4% in the general population—a statistically significant difference.
Additionally, the research highlighted that elevated factor VIII levels were associated with a 24% higher risk of cognitive decline. AB blood carriers, on average, exhibited higher factor VIII, suggesting a potential biological link, though subsequent studies have challenged this association.
Piksel/Getty Images
A 2015 PLOS One analysis of over 1.6 million blood donors in Sweden and Denmark identified 3,615 Alzheimer’s cases, 1,842 vascular dementia cases, and 9,091 unspecified dementia cases. This large‑scale study found no significant relationship between ABO blood group and the risk of Alzheimer’s, vascular, or unspecified dementia, calling into question the earlier Neurology findings.
Other research points to a broader context: a 2022 Neurology study reported that blood type A is linked to a 16% higher stroke risk, while type O carries a 12% lower risk. Since strokes and related conditions—such as hypertension and obesity—are known contributors to memory decline, the apparent association between AB blood and cognitive issues may reflect an elevated stroke risk rather than a direct neurodegenerative pathway.
Moreover, the 2014 study noted that ABO blood types are already implicated in coronary heart disease, stroke, and venous thromboembolism. These comorbidities could underlie the observed cognitive outcomes, underscoring the complexity of the relationship.
As research continues, understanding how blood type intersects with neurological health will become clearer. For those with the rare AB type, staying informed remains essential for proactive health management.
